Bristol Myers Squibb and Acceleron Pharma Inc. announced that the European Commission (EC) has approved Reblozyl (luspatercept) for the treatment of: Adult patients with transfusion─dependent anemia due to very low─...
Latest articles
Moderna to begin testing its COVID-19 vaccine in 30,000 people starting in July
Moderna is to start testing 30,000 people with its coronavirus vaccine beginning in July, after progressing through various trials. The company has finalized the Phase 3 clinical trial structure for its COVID-19...
Promising path found for COVID-19 therapeutics
COVID-19 therapeutics A team of researchers at the University of Georgia has successfully demonstrated that a set of drug-like small molecules can block the activity of a key SARS-CoV-2 protein – providing a...
Social crisismarketing, wat kunnen we ervan leren?
Social crisismarketing Veel organisaties konden hun product of dienst door de coronacrisis en de opgelegde overheidsmaatregelen niet verkopen, waardoor ‘harde’ conversiegedreven campagnevoering via social voor hen...
How novel coronavirus affects children
Coronavirus and children New insights into the clinical and epidemiological characteristics of pediatric patients with coronavirus disease 2019 (COVID-19) could facilitate early identification and intervention in...
Asthma Isn’t a Risk Factor for Worsening COVID-19: Study
Asthma FRIDAY, June 19, 2020 — People with asthma can breathe a little easier: New research suggests the condition does not increase your risk of hospitalization due to COVID-19.A review of records from 10...
